Erik Jessen
Impact in
-
- Bacterial Genetics and Biotechnology
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Surgery 7
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Co-authors
- Rachel A. Mooney (1 shared paper)Jason M. Peters (1 shared paper)Robert Landick (1 shared paper)Frances Tran (1 shared paper)Jeffrey A. Grass (1 shared paper)Shaji Kumar (6 shared papers)Dragan Jevremović (4 shared papers)Surendra Dasari (4 shared papers)
- Journals
- Cancer Research (3 papers)Science Advances (2 papers)Blood Cancer Journal (2 papers)American Journal of Clinical Pathology (2 papers)Human Reproduction (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Erik Jessen
25 papers receiving 368 citations
Peers
Comparison fields: 5 of 63
- Genetics 162
- Hematology 61
- Molecular Biology 269
- Ecology 75
- Cancer Research 33
Countries citing papers authored by Erik Jessen
This map shows the geographic impact of Erik Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jessen more than expected).
Fields of papers citing papers by Erik Jessen
This network shows the impact of papers produced by Erik Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jessen. The network helps show where Erik Jessen may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Jessen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 202 | |
| 2 | 2019 | 27 | |
| 3 | 2020 | 23 | |
| 4 | 2020 | 22 | |
| 5 | 2019 | 16 | |
| 6 | 2021 | 9 | |
| 7 | 2020 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2020 | 7 | |
| 11 | 2014 | 6 | |
| 12 | 2014 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 4 | |
| 16 | Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d. | 1985 | 4 |
| 17 | 2025 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Erik Jessen
Erik Jessen is a scholar working on Molecular Biology, Surgery, Oncology, Hematology and Immunology, having authored 28 papers that have together received 373 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer Mechanisms and Therapy (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Genetics (162 citations), Hematology (61 citations), Molecular Biology (269 citations), Ecology (75 citations) and Cancer Research (33 citations). Erik Jessen has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Rachel A. Mooney, Jason M. Peters, Robert Landick, Frances Tran, Jeffrey A. Grass, Shaji Kumar, Dragan Jevremović, Surendra Dasari, Taro Hitosugi and Wilson I. Gonsalves. Their work appears in journals such as Cancer Research, Science Advances, Blood Cancer Journal, American Journal of Clinical Pathology and Human Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.